https://doi.org/10.1016/j.msard.2020.102018

2. Ogawa, R., et al. (2017) MOG Antibody—Positive, Benign, Unilateral, Cerebral Cortical Encephalitis with Epilepsy. Neurology—Neuroimmunology Neuroinflammation, 4, e322. https://doi.org/10.1212/NXI.0000000000000322

3. Matesanz, S., Kotch, C., Perrone, C., et al. (2019) Expanding the MOG Phenotype: Brainstem Encephalitis with Punctate and Curvilinear Enhancement. Neurology Neuroimmunology & Neuroinflammation, 6, e619. https://doi.org/10.1212/NXI.0000000000000619

4. Ramanathan, S., Fraser, C., Curnow, S.R., et al. (2019) Uveitis and Optic Perineuritis in the Context of Myelin Oligodendrocyte Glycoprotein Antibody Seropositivity. European Journal of Neurology, 26, 1137-e75. https://doi.org/10.1111/ene.13932

5. Sebastian, L., Masoud, M., James, F., et al. (2018) Association of MOG-IgG Serostatus with Relapse after Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. JAMA Neurology, 75, 1355-1363.

6. Bruijstens, A.L., Lechner, C., Flet, B.L., et al. (2020) E.U. Paediatric MOG Consortium Consensus: Part 1—Classifica- tion of Clinical Phenotypes of Paediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders. European Journal of Paediatric Neurology, 29, 2-13. https://doi.org/10.1016/j.ejpn.2020.10.006

7. 杨坤芳, 陈育才. 儿童多发性硬化和其他中枢神经系统脱髓鞘疾病诊断标准的国际儿童多发性硬化研究小组共识(2012版) [C]//第十三届江浙沪儿科学术会议暨2016年浙江省医学会儿科学学术年会. 湖州: 浙江省医学会儿科学分会、江苏省医学会儿科学分会、上海市医学会儿科学分会: 浙江省科学技术协会, 2016: 2.

8. Jarius, S., Paul, F., Aktas, O., et al. (2018) MOG Encephalomyelitis: International Recommendations on Diagnosis and Antibody Testing. Journal of Neuroinflammation, 15, 134. https://doi.org/10.1186/s12974-018-1144-2

9. 中国免疫学会神经免疫分会, 邱伟, 徐雁. 抗髓鞘少突胶质细胞糖蛋白免疫球蛋白G抗体相关疾病诊断和治疗中国专家共识[J]. 中国神经免疫学和神经病学杂志, 2020, 27(2): 86-95.

10. Wynford-Thomas, R., Jacob, A. and Tomassini, V. (2019) Neurological Update: MOG Antibody Disease. Journal of Neurology, 266, 1280-1286. https://doi.org/10.1007/s00415-018-9122-2

11. Ramanathan, S., Dale, R.C. and Brilot, F. (2016) Anti-MOG Antibody: The History, Clinical Phenotype, and Pathogenicity of a Serum Biomarker for Demyelination. Autoimmunity Reviews, 15, 307-324. https://doi.org/10.1016/j.autrev.2015.12.004

12. 董会卿. MOG抗体介导的特发性炎性脱髓鞘疾病[J]. 中国神经免疫学和神经病学杂志, 2017, 24(2): 88-91.

13. 周红雨, 张勤. 髓鞘少突胶质细胞糖蛋白抗体和其他自身免疫抗体并存的临床诊疗涵义[J]. 中华医学杂志, 2020, 100(5): 324-327.

14. 谭建敏. MOG抗体在中枢神经系统炎性脱髓鞘疾病中的诊断价值[J]. 现代医药卫生, 2018, 34(17): 2657-2659.

15. Leite, M.I. and Sato, D.K. (2019) MOG-Antibody-Associated Disease Is Different from MS and NMOSD and Should Be Considered as a Distinct Disease Entity—Yes. Multiple Sclerosis, 26, 272-274. https://doi.org/10.1177/1352458519868796

16. Fan, S., Xu, Y., Ren, H., et al. (2018) Comparison of Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Disease and AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) When They Co-Exist with Anti-NMDA (N-methyl-D-aspartate) Receptor Encephalitis. Multiple Sclerosis & Related Disorders, 20, 144-152. https://doi.org/10.1016/j.msard.2018.01.007

17. Shahriari, M., Yousem, D.M., Sotirchos, E.S., et al. (2020) MOG Antibody Associated Disease: How It Differs from and Resembles Other Neuroinflammatory Disorders. American Journal of Roentgenology, 216, 1031-1039. https://doi.org/10.2214/AJR.20.24061

18. Chen, C., Liu, C., Fang, L., et al. (2019) Different Magnetic Resonance Imaging Features between MOG Antibody- and AQP4 Antibody-Mediated Disease: A Chinese Cohort Study. Journal of the Neurological Sciences, 405, Article ID: 116430. https://doi.org/10.1016/j.jns.2019.116430

19. Tenembaum, S.N. (2021) Pediatric Demyelinating Disease and Anti-MOG Antibody. Clinical and Experimental Neuroimmunology, 12, 5.

20. 周少旦, 付桔, 卜秀群, 等. 17例髓鞘少突胶质细胞糖蛋白抗体相关疾病患者的临床分析[J]. 中风与神经疾病杂志, 2020, 37(12): 1105-1108.

21. 孙红, 谭建敏, 刘静临, 等. 儿童髓鞘少突胶质细胞糖蛋白抗体相关脱髓鞘病57例临床特征及预后分析[J]. 临床儿科杂志, 2020, 38(11): 30-36.

22. 徐敏, 郭虎, 何燕, 等. 儿童髓鞘少突胶质细胞糖蛋白抗体脑脊髓炎13例临床与影像学特征[J]. 中华实用儿科临床杂志, 2019, 34(13): 997-1001.

23. Armangue, T., Olivé-Cirera, G., Martínez-Hernandez, E., et al. (2020) Associations of Paediatric Demyelinating and Encephalitic Syndromes with Myelin Oligodendrocyte Glycoprotein Antibodies: A Multicentre Observational Study. The Lancet Neurology, 19, 234-246.

24. Serin, H.M., Yilmaz, S., Simsek, E., et al. (2020) Clinical Spectrum, Treatment and Outcome of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease in Children: A Tertiary Care Experience. Acta Neurologica Belgica, 121, 231-239. https://doi.org/10.1007/s13760-020-01499-9

25. Zhou, Y., Jia, X., Hui, Y., et al. (2018) Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Demyelination: Comparison between Onset Phenotypes. European Journal of Neurology, 26, 175-183. https://doi.org/10.1111/ene.13791

26. Salama, S., Khan, M., Pardo, S., et al. (2019) MOG Antibody-Associated Encephalomyelitis/Encephalitis. Multiple Sclerosis, 25, 1427-1433. https://doi.org/10.1177/1352458519837705

●投稿须知

●最新文章